Company News: Sanofi-Aventis and Warner Chilcott

Share this article:
Sanofi-Aventis handed over Actonel marketing rights in the US to its collaborator on the drug, Warner Chilcott. Under the new agreement, Warner Chilcott will take full operational control over promotion, marketing and R&D decisions in the US and Puerto Rico. As part of the deal, Warner Chilcott will offer "a number of sales reps currently promoting Actonel for Sanofi-Aventis" jobs on the Warner Chilcott sales force, according to a company statement.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.